Prakiraan pendapatan perusahaan: MacroGenics Inc (MGNX)

MacroGenics Corp - logo grafis emiten MGNX

Patents for DART platforms and stringent FDA oversight create barriers that, combined with pressure from pharma behemoths, drive volatility. The trend of MacroGenics, Inc. (MGNX) future sales visualizes this confrontation, where the current mark equals 0.11. The development of MacroGenics, Inc. (MGNX) relies on a specific rollout cycle for targeted drugs, making commercial success the primary driver regardless of the external economy.

Volume dodolan mangsa ngarep perusahaan: MacroGenics Inc. (MGNX) kanggo 04.07.2022 - 15.11.2026

Rincian metrik lan analitis perusahaan MacroGenics Inc. (MGNX)

- kuotasi lan prakiraan analis:
Rega saham MacroGenics Inc.|MGNX - Rata-rata rega prakiraan
- indikator kapitalisasi bursa perusahaan:
Nilai pasar MacroGenics|MGNX - Nilai Dipunlarasaken Utang lan Kas
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham MacroGenics|MGNX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku macrogenics.com|MGNX - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal MacroGenics, Inc.|MGNX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas MacroGenics, Inc.|MGNX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku MacroGenics Inc|MGNX - Utang jangka dawa|Utang jangka cendhak perusahaan MacroGenics|Rasio cepet macrogenics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
MGNX - Penghasilan resik perusahaan|Bathi sing dikarepake MacroGenics, Inc.|MGNX - Pangali rega marang bathi|Pangali Forward P/E MacroGenics Inc.|MGNX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA MacroGenics|MGNX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan MacroGenics|MGNX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan macrogenics.com|MGNX - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep MacroGenics, Inc.
- data total pendapatan lan volume dodolan:
MGNX - Pendapatan reged perusahaan|Prakiraan pendapatan perusahaan MacroGenics Corp|MGNX - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S MacroGenics|MGNX - Wutah pendapatan YoY sajrone 12 wulan kepungkur
Pambiji fundamental:MGNX MacroGenics Inc.
Produk merek MacroGenics Corp

Future sales volume represents the aggregate analyst consensus forecast for the business's expected cash inflows. For MacroGenics, Inc. (MGNX), this metric reflects the monetization potential of the DART platform and future licensing payments from partners. By analyzing the future sales volume chart, an investor assesses market expectations regarding the commercialization of oncology drugs. This metric measures fundamental revenue stability through the lens of future contracts. The indicator's trend confirms or refutes the validity of the current market value of the shares.

Pesaing MacroGenics, Inc. (MGNX)

Prakiraan volume dodolan OLMA|PBYI - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Greenwich LifeSciences, Inc GLSI|Pendapatan mangsa ngarep perusahaan ZNTL|PSTV - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan PCSA|EGRX: Prakiraan volume dodolan